Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor von Kavanaugh, Arthur, Mease, Philip J., Gómez-Reino, Juan J., Adebajo, Adewale O., Wollenhaupt, Jürgen, Gladman, Dafna D., Lespessailles, Eric, Hall, Stephen, Hochfeld, Marla, Hu, Chiachi, Hough, Douglas, Stevens, Randall M., Schett, Georg

kostenfrei
kostenfrei
kostenfrei

Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis pooled analysis of two phase 3 studies von Coates, Laura C., Wallman, Johan K., McGonagle, Dennis, Schett, Georg A., McInnes, Iain B., Mease, Philip J., Rasouliyan, Lawrence, Quebe-Fehling, Erhard, Asquith, Darren L., Fasth, Andreas E. R., Pricop, Luminita, Gaillez, Corine

kostenfrei
kostenfrei
kostenfrei

Long-term experience with apremilast in patients with psoriatic arthritis 5-year results from a PALACE 1–3 pooled analysis von Kavanaugh, Arthur, Gladman, Dafna D., Edwards, Christopher J., Schett, Georg, Guerette, Benoit, Delev, Nikolay, Teng, Lichen, Paris, Maria, Mease, Philip J.

kostenfrei
kostenfrei
kostenfrei

Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years results from the FUTURE 2 study von McInnes, Iain B., Mease, Philip J., Schett, Georg, Kirkham, Bruce, Strand, Vibeke, Williams, Nicole, Fox, Todd, Pricop, Luminita, Jugl, Steffen M., Gandhi, Kunal K.

kostenfrei
kostenfrei
kostenfrei

Atlas of psoriatic arthritis

Weitere Verfasser: “… Mease, Philip J. 1951- …”
BFB01
BSB01
BTU01
BTW01
EUV01
FAN01
FAW01
FAW02
FCO01
FFW01
FHI01
FHM01
FHN01
FHR01
FKE01
FLA01
FNU01
FWS01
FWS02
HWR01
LCO01
SAB01
SAM01
SBG01
SBR01
SND01
TUM01
UBA01
UBG01
UBM01
UBR01
UBT01
UBW01
UBY01
UER01
UPA01
Volltext